Sponsor:
Main Line Health
Code:
NCT06439524
Conditions
Endometriosis
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone acetate
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Main Line Health on 2024-12-06.